| Ticker | ONWD (Euronext) |
|---|---|
| Headquarters | Eindhoven, Netherlands |
| Founded | 2014 |
| Status | Clinical Stage |
| Website | onwardmedical.com |
| IPO | Euronext Amsterdam, 2021 |
| Funding | €150M+ raised |
| Market Cap | ~€200M (2024) |
Onward Medical is a medical technology company developing innovative therapies for spinal cord injury (SCI) recovery. The company's ARC Therapy platform uses targeted, programmable spinal cord stimulation to restore movement, bladder function, and blood pressure regulation in patients with spinal cord injuries[1]. Founded in 2014 as a spinout from the Swiss Federal Institute of Technology (ETH Zurich), Onward Medical represents a significant advancement in the field of neuroprosthetics for spinal cord injury rehabilitation[2][3].
Onward Medical operates at the intersection of neurotechnology, neuromodulation, and rehabilitation medicine, targeting a significant unmet need in spinal cord injury care. The company's mission is to restore independence and quality of life for the millions of people worldwide living with spinal cord injury through innovative neurotechnology solutions[4].
Spinal cord stimulation for functional restoration operates on the principle that the neural circuits below a spinal cord injury remain structurally intact but lack sufficient excitatory input to generate functional output. The spinal cord contains the central pattern generators (CPGs) for locomotion, which can be activated by appropriate sensory input or direct electrical stimulation[5][6].
Key principles underlying Onward's technology include:
Residual Neural Circuitry: Even after severe spinal cord injury, the neural networks below the injury site retain the capacity for functional activity. These circuits can be activated through targeted electrical stimulation.
Activity-Dependent Plasticity: The nervous system exhibits remarkable capacity for adaptation when provided with appropriate activity. Repeated, task-specific training combined with neuromodulation can strengthen existing connections and promote new ones.
Sensory Feedback Integration: The ARC Therapy platform is designed to work synergistically with residual sensory signals from the brain, creating a closed-loop system that enhances motor control.
The fundamental mechanism involves delivering electrical currents to specific regions of the spinal cord, activating the dorsal roots and intraspinal networks that control motor neurons for specific muscle groups[7][8].
The field of spinal cord stimulation for functional restoration has evolved significantly over decades:
Onward's flagship technology involves implantable electrodes placed on the spinal cord that deliver patterned electrical stimulation:
Device Components:
Technical Specifications:
Onward's platform addresses multiple functional domains affected by spinal cord injury:
1. Movement Restoration
The primary application involves enabling voluntary leg movement and walking:
2. Bladder Function Restoration
Spinal cord injury frequently disrupts bladder control, leading to urinary incontinence and retention:
3. Blood Pressure Regulation
Many individuals with spinal cord injury experience orthostatic hypotension due to impaired autonomic control:
Onward Medical distinguishes itself through several technological features:
| Feature | Onward ARC Therapy | Traditional Approaches |
|---|---|---|
| Stimulation Type | Programmable, patterned | Fixed patterns |
| Targeting | Multi-segment, precise | Single-level |
| Integration | Brain signals + stimulation | Stimulation alone |
| Mapping | Non-invasive external | Surgical only |
| Adaptability | Real-time adjustment | Limited adjustment |
The key differentiator is the integration of brain-computer interface concepts—using signals from the patient's own brain to guide the timing and pattern of spinal stimulation to achieve the patient's intended movement[9][10].
Onward's pivotal study for regulatory approval in Europe represents one of the most comprehensive clinical investigations of spinal cord stimulation for functional restoration:
Trial Design:
Results:
The clinical evidence supporting ARC Therapy includes multiple peer-reviewed publications:
| Study | Year | Key Findings |
|---|---|---|
| Rowald et al., Nat Med | 2022 | Activity-dependent neuromodulation rapidly restores trunk and leg motor functions |
| Wagner et al., Swiss Med Wkly | 2018 | Roadmap to comprehensive spinal cord injury center |
| Courtine et al., Nat Neurosci | 2013 | Transformation of non-functional spinal circuits into functional ones after paralysis |
| Gerasimenko et al., Prog Brain Res | 2016 | Neuromodulation of spinal neuronal networks in locomotion |
| Kappos et al., Nat Med | 2018 | Non-invasive spinal cord stimulation for arm and hand function |
Spinal cord injury represents a significant global health burden:
The economic consequences of spinal cord injury are substantial:
Onward Medical operates in the neuroprosthetics and spinal cord stimulation space alongside:
| Company | Technology | Status |
|---|---|---|
| Onward Medical | ARC Therapy (epidural stimulation) | CE Mark, FDA pivotal planned |
| Nalu Medical | Minimally invasive spinal cord stimulation | FDA cleared |
| Saluda Medical | Closed-loop spinal cord stimulation | FDA cleared |
| Medtronic | Traditional SCS for pain | Commercial |
| Abbott | Dorsal root ganglion stimulation | Commercial |
Onward Medical maintains strategic partnerships with leading institutions:
Onward is advancing multiple programs beyond the initial movement restoration indication:
Future technology developments include:
Non-invasive spinal cord stimulation for arm and hand function in chronic tetraplegia. Nat Med. 2018. ↩︎
Epidural stimulation of the cervical spinal cord for upper-extremity function. Lancet. 2019. ↩︎
Swiss paralysis foundation: the roadmap to a comprehensive spinal cord injury center. Swiss Med Wkly. 2018. ↩︎
Neuromodulation of spinal neuronal networks in locomotion. Prog Brain Res. 2016. ↩︎
Transformation of non-functional spinal circuits into functional ones after paralysis. Nat Neurosci. 2013. ↩︎
Step-like spinal cord stimulation to restore walking. Nat Rev Neurol. 2019. ↩︎
Corticospinal neuroprosthetics to restore hand function. Nat Rev Neurol. 2013. ↩︎
Walking naturally after spinal cord injury using a brain-spine interface. Nature. 2018. ↩︎
Targeted epidural spinal stimulation restores walking after paralysis. Nat Med. 2023. ↩︎